ORLANDO, Fla., Aug. 6, 2008 (PRIME NEWSWIRE) -- RedChip Visibility, a division of RedChip Companies, Inc., has issued a fourth quarter fiscal 2008 research report update for GeoPharma, Inc. (Nasdaq:GORX), a company specializing in the manufacture and distribution of over-the-counter, nutritional, generic drug and functional food products.
Richa Kalia, MA, RedChip Research Analyst, reported:
"GORX entered into an agreement with the University of South Florida Research Foundation in December 2007 to acquire worldwide patent rights to a diagnostic kit technology for early stage detection of ovarian cancer using a patient's urine samples. Management plans to develop and commercialize the product in-house. With no approved ovarian cancer screener in the U.S. market, GORX has first-mover advantage, and we believe the Company will be able to capitalize on the untapped market potential and enhance its market share.
"We continue to reiterate our 'Speculative Buy' recommendation for GORX with a revised price target of $5.05 per share," she concluded.
To receive a complimentary copy of the RedChip Visibility Fourth Quarter Research Report for GeoPharma, Inc., please visit:
http://www.redchip.com/visibility/about.asp?page=vreport&reportid=130&from=08062008pr
About RedChip Companies, Inc.
RedChip Companies is an international, small-cap research and financial public relations firm with offices in Orlando, Florida; Shanghai; and Paris, with affiliates in Atlanta, San Diego, and New York. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research(tm), Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Internet TV(tm), and RedChip Radio(tm). To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/productsandservices.asp.
"Discovering Tomorrow's Blue Chips Today"(tm)
The RedChip Companies, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=2761
DISCLOSURE:
None of the profiles issued by RedChip Companies, Inc., constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. Any investor should determine whether a particular security is suitable based on the investor's objectives, other securities holdings, financial situation needs, and tax status. GeoPharma, Inc. paid RedChip Visibility $49,000 for 12 months of the RedChip Visibility Research Program services, which includes the preparation of this equity research report. RedChip Companies, Inc., employees and affiliates may have positions and affect transactions in the securities or options of the issuers mentioned herein. To the fullest extent permissible under applicable law, RedChip Companies, Inc., will not be liable to you or anyone else for the quality, accuracy, completeness, reliability, or timeliness of this information.